These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28381688)

  • 1. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
    Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
    Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
    Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
    Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
    Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A boy with fever, lymphadenopathy, hepatosplenomegaly, and lymphocytosis.
    Kaza U; Knight AK; Jeroudi M; Bocchini JA; Anga A; Bahna SL
    Allergy Asthma Proc; 2008; 29(2):216-20. PubMed ID: 18430321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection triggering a haemophagocytic syndrome.
    Olaya M; Alsina L; de Sevilla MF; Catalá A; López-Ramos MG; Martín Mateos MA; Plaza AM
    Allergol Immunopathol (Madr); 2014; 42(6):627-9. PubMed ID: 24231151
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
    Lee JS; Kang JH; Lee GK; Park HJ
    J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.
    Imashuku S
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):35-9. PubMed ID: 21088619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis.
    Lee WJ; Lee DW; Kim CH; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Am J Dermatopathol; 2010 Jun; 32(4):357-61. PubMed ID: 20010284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case report: a case of Epstein-Barr virus associated hemophagocytic syndrome with reversible leukoencephalopathy in the splenium of the corpus callosum].
    Otaka Y; Sakurai Y; Soma H; Watanabe T; Goda F; Sato M
    Nihon Naika Gakkai Zasshi; 2013 Jul; 102(7):1804-6. PubMed ID: 23947245
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
    Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y
    J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.
    Takahashi M; Makino S; Iizuka H; Noguchi M; Yoshida K
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):681. PubMed ID: 34620104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis.
    Sathiyamoorthy S; Shad A; Ozdemirli M
    Pediatr Blood Cancer; 2011 May; 56(5):850-2. PubMed ID: 21370422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
    Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological presentation of hemophagocytic lymphohistiocytosis.
    Kamila ŻW; Teresa R; Patrycja MG; Andrzej S
    Neurol Neurochir Pol; 2015; 49(5):329-31. PubMed ID: 26377985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
    Matsuo Y; Iwanami K; Hiraoka E; Oda R
    Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.
    Cai L; Xing Y; Xia Y; Zhang Z; Luo Z; Tang Y; Chen Y; Xu X
    BMC Infect Dis; 2023 Oct; 23(1):728. PubMed ID: 37880605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
    Sinno MG; Rosen D; Wittler R
    Pediatr Blood Cancer; 2016 Aug; 63(8):1474-6. PubMed ID: 27148941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis.
    Haruta K; Suzuki T; Yamaguchi M; Fukuda Y; Torii Y; Takahashi Y; Ito Y; Kawada JI
    J Med Virol; 2024 Feb; 96(2):e29450. PubMed ID: 38304956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.